![Nithya Desikan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nithya Desikan
Directeur/Membre du Conseil chez
PARATEK PHARMACEUTICALS, INC.
Profil
Nithya Desikan is currently Director at Corium LLC, Director at Paratek Pharmaceuticals, Inc., and Operating Partner at Gurnet Point Capital LLC.
Formerly, Ms. Desikan was Vice President at Biogen, Inc. from 2016 to 2017 and Chief Commercial Officer at Rhythm Pharmaceuticals, Inc. from 2017 to 2020.
Education includes undergraduate studies at the University of Florida.
Postes actifs de Nithya Desikan
| Sociétés | Poste | Début |
|---|---|---|
| PARATEK PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | - |
Corium LLC
 Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Directeur/Membre du Conseil | - |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Private Equity Investor | - |
Northill Capital LLP
 Northill Capital LLP Investment ManagersFinance Northill Capital invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Private Equity Investor | - |
Anciens postes connus de Nithya Desikan
| Sociétés | Poste | Fin |
|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 30/09/2020 |
| BIOGEN INC. | Corporate Officer/Principal | 01/07/2017 |
Formation de Nithya Desikan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
28
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Rhythm Pharmaceuticals, Inc.
 Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northill Capital LLP
Northill Capital LLP Investment ManagersFinance Northill Capital invests in companies located in the United Kingdom. The firm focuses on life sciences, healthcare services and digital health sectors. It participates in seed and buyout transactions. | Finance |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Corium LLC
Corium LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel neuroscience therapies | Health Technology |
